| Literature DB >> 28078953 |
Amy Corneli1,2, Emily Namey1, Monique P Mueller1, Jenae Tharaldson1, Steve Sortijas1, Thomas Grey1, Jeremy Sugarman3.
Abstract
Long informed consent forms (ICFs) remain commonplace, yet they can negatively affect potential participants' understanding of clinical research. We aimed to build consensus among six groups of key stakeholders on advancing the use of shorter ICFs in clinical research. Partnering with the HIV Prevention Trials Network (HPTN), we used a modified Delphi process with semistructured interviews and online surveys. Concerns about redundancy of information were common. Respondents supported three strategies for reducing ICF length: (a) 91% agreed or strongly agreed with grouping study procedures by frequency, (b) 91% were comfortable or very comfortable with placing supplemental information into appendices, and (c) 93% agreed or strongly agreed with listing duplicate side effects only once. Implementing these strategies will facilitate adoption of the proposed changes to U.S. regulations on ICF length, should they be enacted.Entities:
Keywords: HIV; U.S. regulations; consent forms; informed consent; research ethics
Mesh:
Year: 2017 PMID: 28078953 PMCID: PMC5821132 DOI: 10.1177/1556264616682550
Source DB: PubMed Journal: J Empir Res Hum Res Ethics ISSN: 1556-2646 Impact factor: 1.742